Chordia Therapeutics Inc. (JP:190A) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Chordia Therapeutics Inc. reports a net loss of 1,177 million yen for the nine months ending May 31, 2024, with a significant decrease in net assets from the previous period. Despite the financial downturn, the company’s equity ratio remains high at 95.2%. No dividends have been announced, and the company cautions that actual financial results may vary from forecasts.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.